Abstract:Background Gut microbiota plays critical roles in nonalcoholic fatty liver disease (NAFLD). We have previously isolated and identified one clinical Escherichia coli (E. coli) strain from the intestinal mucosa of a nonalcoholic steatohepatitis (NASH) patient, and named it as E. coli NF73-1. Our aim is to investigate the role of E. coli NF73-1 in the development of NAFLD in a high-fat diet (HFD) mice. Methods Conventional (CV) mice, plus mice treated with antibiotics (AB) to deplete gut microbiota, were fed with HFD for 12 weeks. At the 10th week, mice were treated daily with oral gavage of LB, live-NF73-1, or pasteurized-NF73-1 (pas-NF73-1) for 2 weeks. AB mice were treated in drinking water containing 1 g/L ampicillin, 500 mg/L vancomycin, 1 g/L neomycin, and 1 g/L metronidazole for 4 weeks, starting at 6th week. In vitro bacterial translocation and transepithelial permeability assay was performed. Primary hepatocytes from NAFLD mice were cocultured with NF73-1 to evaluate inflammatory responses. Results Live-NF73-1 group developed severer liver pathology than LB and pas-NF73-1 groups in both CV and AB mice, verified by increased NAFLD activity (NAS) score. Besides, intestinal permeability was higher in live-NF73-1 group than that in LB and pas-NF73-1 groups of both CV and AB mice, supported by decreased expression of ZO-1 and Occludin in the colon. In vitro bacterial translocation and transepithelial permeability assay indicated that HT-29 cells treated with live-NF73-1 developed a higher concentration of translocated bacteria and FITC fluorescein than LB and pas-NF73-1 groups. Interestingly, live-NF73-1 decreased mRNA levels of ZO-1, Occludin and Claudin2 in Caco2 cells, and downregulated mRNA expression of Claudin2 and E-cadherin in HT-29 cells compared with LB and pas-NF73-1 groups. NF73-1 also induced inflammatory responses of primary hepatocytes, supported by increased IL-6 expression. Conclusions Clinical E. coli NF73-1 aggravates liver injury in NAFLD mice, through impaired intestinal integrity and inflammatory responses in hepatocytes. These findings provide new insights on management using specific bacterial strain.

Mesenteric Lymph Node CD4+ T Lymphocytes Migrate to Liver and Contribute to Non-Alcoholic Fatty Liver Disease.

Gut‐derived lymphocyte recruitment to liver and induce liver injury in non‐alcoholic fatty liver disease mouse model

Aberrant Hepatic Microrna Expression in Nonalcoholic Fatty Liver Disease

Mesenteric Adipose Tissue B Lymphocytes Promote Local and Hepatic Inflammation in Non‐alcoholic Fatty Liver Disease Mice

Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease

Increased Number of Mucosal-Associated Invariant T Cells Is Associated with the Inhibition of Nonalcoholic Fatty Liver Disease in High Fat Diet-Fed Mice

CD4+ T Cells Mediate the Development of Liver Fibrosis in High Fat Diet-Induced NAFLD in Humanized Mice

Roles of Micrornas in Immunopathogenesis of Non-Alcoholic Fatty Liver Disease Revealed by Integrated Analysis of Microrna and Mrna Expression Profiles

The role of Th2 in immune surveillance of NAFLD-associated liver metastasis

Intestinal Immune Barrier Integrity in Rats with Nonalcoholic Hepatic Steatosis and Steatohepatitis.

Dietary Factors Alter Hepatic Innate Immune System in Mice with Nonalcoholic Fatty Liver Disease

Gut microbe and hepatic macrophage polarization in non-alcoholic fatty liver disease

The contribution of the gut-liver axis to the immune signaling pathway of NAFLD

Gut Inflammation Exacerbates High-Fat Diet Induced Steatosis by Suppressing VLDL-TG Secretion Through HNF4α Pathway

Role of Probiotics in Gut Microbiome and Metabolome in Non-Alcoholic Fatty Liver Disease Mouse Model: A Comparative Study

Obesity-associated mesenteric lymph leakage impairs the trafficking of lipids, lipophilic drugs and antigens from the intestine to mesenteric lymph nodes

IDDF2019-ABS-0334 Clinical Escherichia Coli NF73–1 Isolated from a Patient with Nonalcoholic Steatohepatitis Induces Liver Injury Through Impairing Intestinal Barrier Function and Inducing Inflammatory Responses of Hepatocytes

Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease

Multi-Omics Characterizes the Effects and Mechanisms of CD1d in Nonalcoholic Fatty Liver Disease Development

Association between hepatocyte TM4SF5 expression and gut microbiome dysbiosis during non-alcoholic fatty liver disease development

E. coli NF73-1 Isolated From NASH Patients Aggravates NAFLD in Mice by Translocating Into the Liver and Stimulating M1 Polarization